z-logo
Premium
Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure
Author(s) -
Harjola VeliPekka,
Follath Ferenc,
Nieminen Markku S.,
Brutsaert Dirk,
Dickstein Kenneth,
Drexler Helmut,
Hochadel Matthias,
Komajda Michel,
LopezSendon Jose L.,
Ponikowski Piotr,
Tavazzi Luigi
Publication year - 2010
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1093/eurjhf/hfq002
Subject(s) - medicine , heart failure , intensive care medicine , emergency medicine , cardiology
Aims Acute heart failure (AHF) has a poor prognosis. We evaluated 3‐ and 12‐month mortality in different clinical classes of AHF patients from 30 European countries who were included in the EuroHeart Failure Survey (EHFS) II. Methods and results Follow‐up data were available for 2981 AHF patients, of these 62% had a history of chronic HF. One‐year mortality after discharge was lower in patients with de novo AHF when compared with acutely decompensated chronic HF (ADCHF), 16.4 vs. 23.2% ( P < 0.001). Cardiogenic shock conferred the highest cumulative 1‐year mortality (52.9%) as a result of in‐hospital mortality of 39.3%. Long‐term prognosis in decompensated AHF was also dismal. Hypertensive HF was associated with the lowest mortality (13.7% at 1 year). Age, prior myocardial infarction, creatinine level, and low plasma sodium were independently associated with mortality during the whole follow‐up period. Diabetes, anaemia, and history of chronic HF were associated with worse and hypertension with better long‐term survival. History of cerebrovascular disease was associated with worse short‐term outcome. Conclusion Early and late mortality differ between de novo AHF and ADCHF and between clinical classes of AHF. EHFS II identifies clinical risk markers and demonstrates the importance of a thorough characterization of AHF populations according to history and clinical presentation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here